News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
773,830 Results
Type
Article (54263)
Company Profile (308)
Press Release (719246)
Multimedia
Podcasts (120)
Webinars (23)
Section
Business (215252)
Career Advice (2879)
Deals (37094)
Drug Delivery (143)
Drug Development (86288)
Employer Resources (185)
FDA (17353)
Job Trends (15896)
News (366243)
Policy (35569)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2925)
Academic (1)
Accelerated approval (39)
Adcomms (33)
Allergies (165)
Alliances (52584)
ALS (191)
Alzheimer's disease (1796)
Antibody-drug conjugate (ADC) (361)
Approvals (17567)
Artificial intelligence (600)
Autoimmune disease (192)
Automation (46)
Bankruptcy (387)
Best Places to Work (12167)
BIOSECURE Act (21)
Biosimilars (205)
Biotechnology (201)
Bladder cancer (174)
Brain cancer (67)
Breast cancer (683)
Cancer (5259)
Cardiovascular disease (461)
Career advice (2438)
Career pathing (42)
CAR-T (307)
CDC (62)
Celiac Disease (2)
Cell therapy (820)
Cervical cancer (40)
Clinical research (73568)
Collaboration (1897)
Company closure (4)
Compensation (1235)
Complete response letters (77)
COVID-19 (2926)
CRISPR (107)
C-suite (969)
Cystic fibrosis (150)
Data (6676)
Decentralized trials (2)
Denatured (31)
Depression (161)
Diabetes (540)
Diagnostics (7122)
Digital health (51)
Diversity (13)
Diversity, equity & inclusion (46)
Drug discovery (287)
Drug pricing (217)
Drug shortages (31)
Duchenne muscular dystrophy (259)
Earnings (92347)
Editorial (68)
Employer branding (23)
Employer resources (163)
Events (124232)
Executive appointments (1065)
FDA (20665)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (13)
Frontotemporal dementia (25)
Funding (1599)
Gene editing (224)
Generative AI (51)
Gene therapy (684)
GLP-1 (1109)
Government (5173)
Grass and pollen (8)
Guidances (387)
Healthcare (20127)
HIV (73)
Huntington's disease (53)
IgA nephropathy (89)
Immunology and inflammation (297)
Immuno-oncology (74)
Indications (135)
Infectious disease (3235)
Inflammatory bowel disease (212)
Inflation Reduction Act (15)
Influenza (130)
Intellectual property (265)
Interviews (559)
IPO (17063)
IRA (57)
Job creations (4067)
Job search strategy (1981)
JPM (67)
Kidney cancer (20)
Labor market (90)
Layoffs (620)
Leadership (42)
Legal (8748)
Liver cancer (102)
Longevity (21)
Lung cancer (708)
Lymphoma (393)
Machine learning (47)
Management (63)
Manufacturing (875)
MASH (185)
Medical device (14427)
Medtech (14493)
Mergers & acquisitions (21142)
Metabolic disorders (1427)
mRNA (188)
Multiple sclerosis (179)
NASH (23)
Neurodegenerative disease (373)
Neuropsychiatric disorders (106)
Neuroscience (3195)
Neurotech (1)
NextGen: Class of 2026 (7116)
Non-profit (4923)
Now hiring (69)
Obesity (686)
Opinion (327)
Ovarian cancer (175)
Pain (230)
Pancreatic cancer (251)
Parkinson's disease (317)
Partnered (33)
Patents (540)
Patient recruitment (553)
Peanut (65)
People (63708)
Pharmaceutical (67)
Pharmacy benefit managers (32)
Phase 1 (22880)
Phase 2 (32255)
Phase 3 (24111)
Pipeline (6177)
Policy (341)
Postmarket research (2913)
Preclinical (9765)
Press Release (70)
Prostate cancer (267)
Psychedelics (60)
Radiopharmaceuticals (304)
Rare diseases (991)
Real estate (6419)
Recruiting (77)
Regulatory (26552)
Reports (54)
Research institute (2636)
Resumes & cover letters (456)
Rett syndrome (31)
RNA editing (18)
RSV (86)
Schizophrenia (164)
Series A (270)
Series B (201)
Service/supplier (13)
Sickle cell disease (109)
Special edition (26)
Spinal muscular atrophy (171)
Sponsored (45)
Startups (3888)
State (2)
Stomach cancer (21)
Supply chain (116)
Tariffs (95)
The Weekly (87)
Vaccines (1136)
Venture capital (99)
Weight loss (453)
Women's health (103)
Worklife (22)
Date
Today (34)
Last 7 days (713)
Last 30 days (2900)
Last 365 days (31143)
2026 (5837)
2025 (31465)
2024 (36579)
2023 (41519)
2022 (52730)
2021 (57416)
2020 (56265)
2019 (49496)
2018 (37442)
2017 (34257)
2016 (34110)
2015 (40175)
2014 (34091)
2013 (29463)
2012 (31523)
2011 (32098)
2010 (30278)
Location
Africa (930)
Alabama (89)
Alaska (7)
Arizona (329)
Arkansas (14)
Asia (43617)
Australia (7944)
California (11981)
Canada (3442)
China (1200)
Colorado (501)
Connecticut (511)
Delaware (355)
Europe (97274)
Florida (1786)
Georgia (385)
Hawaii (3)
Idaho (65)
Illinois (956)
India (76)
Indiana (551)
Iowa (23)
Japan (462)
Kansas (130)
Kentucky (45)
Louisiana (34)
Maine (73)
Maryland (1472)
Massachusetts (8648)
Michigan (349)
Minnesota (671)
Mississippi (7)
Missouri (142)
Montana (35)
Nebraska (29)
Nevada (132)
New Hampshire (85)
New Jersey (3189)
New Mexico (31)
New York (3163)
North Carolina (1604)
North Dakota (9)
Northern California (5884)
Ohio (355)
Oklahoma (21)
Oregon (44)
Pennsylvania (2415)
Puerto Rico (25)
Rhode Island (51)
South America (1301)
South Carolina (70)
South Dakota (1)
Southern California (4676)
Tennessee (192)
Texas (1855)
United States (42701)
Utah (361)
Vermont (1)
Virginia (285)
Washington D.C. (86)
Washington State (977)
West Virginia (4)
Wisconsin (122)
Wyoming (2)
773,830 Results for "medipurpose inc formerly known as surgilance inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Otsuka Pharmaceutical Canada Inc. and Lundbeck Canada Inc. secure public reimbursement of ABILIFY ASIMTUFII®
March 4, 2026
·
6 min read
Press Releases
Co-Diagnostics, Inc. Performs Analysis of Chikungunya Co-Primers® to Confirm Reactivity Against Known Virus Strains
September 12, 2025
·
4 min read
Press Releases
Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026
March 4, 2026
·
1 min read
Press Releases
Therma Bright Inc. Investee Company, InStatin Expands its Inhaled Statin Programs to include COPD (Chronic Obstructive Pulmonary Disease) as its Lead Indication.
Includes Asthma in its strategic plans and Strengthens its Team in 2024-2025
December 18, 2025
·
5 min read
Press Releases
Breath Diagnostics, Inc. Receives FDA Breakthrough Device Designation for OneBreath™ Platform to Aid Pre-Operative Pneumonia Risk Assessment
February 19, 2026
·
6 min read
Press Releases
/C O R R E C T I O N -- HLS Therapeutics Inc./
March 5, 2026
·
7 min read
Press Releases
Progyny, Inc. Announces Fourth Quarter 2025 Results
February 27, 2026
·
30 min read
Press Releases
Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements
January 13, 2026
·
3 min read
Press Releases
Liminatus Pharma, Inc. Announces Pricing of $4.0 Million Public Offering
February 17, 2026
·
4 min read
Press Releases
FibroBiologics, Inc. Announces Issuance of U.S. Patent Covering Fibroblast Cell Therapy for the Treatment of Osteoporosis
March 2, 2026
·
5 min read
1 of 77,383
Next
